Carus Group

Carus Animal Health is a venture-led biotechnology company focused on identifying and developing innovative technologies for the global animal health market. Operating as a subsidiary of Kyoritsu Seiyaku, Japan's leading animal health company, Carus acts as a bridge for human biotech and medtech firms to adapt their proprietary technologies for veterinary applications. The company's business model involves partnering with early-stage firms to provide investment, regulatory expertise, and clinical development pathways. Their current pipeline includes diverse therapeutic modalities such as cell therapies for canine urinary incontinence and small molecules for respiratory diseases in livestock. Carus Animal Health is headquartered in the United Kingdom and maintains a strategic focus on addressing unmet needs in both companion and production animal medicine.